Lifestyle Medicine and Type 1 Diabetes in Viet Nam: Nutrition, Exercise Safety, and Continuity of Insulin Therapy

Lifestyle Medicine and Type 1 Diabetes in Viet Nam: Nutrition, Exercise Safety, and Continuity of Insulin Therapy

Last reviewed: October 30, 2026

For someone living with type 1 diabetes, going for a morning run can involve more planning than most people realize. Before leaving home, they may need to consider their glucose level, recent insulin administration, what they ate for breakfast and whether their glucose could fall several hours after exercising. Even a familiar activity may not produce the same glucose response every time.

Food choices can present similar challenges. Someone who reduces carbohydrate intake may notice fewer glucose fluctuations after meals, but the change can also affect their insulin requirements. Without appropriate monitoring and treatment adjustments, an attempt to improve their diet could increase the risk of hypoglycemia or other complications.

These situations show why Lifestyle Medicine needs to be applied carefully in type 1 diabetes. Healthy eating, regular physical activity, restorative sleep, stress management, avoiding harmful substances and maintaining supportive relationships can all contribute to better health. However, established type 1 diabetes involves severe insulin deficiency, usually caused by autoimmune destruction of pancreatic beta cells. Insulin replacement remains essential, regardless of how successfully someone manages other aspects of their lifestyle.

For healthcare professionals in Viet Nam, the challenge is to help people benefit from healthier living while ensuring that insulin treatment, glucose monitoring and access to ongoing care remain safe and reliable.

Understanding What Makes Type 1 Diabetes Different

Type 1 diabetes is often associated with childhood and adolescence, but it can develop at any age. Adult-onset type 1 diabetes is well recognized, and distinguishing it from type 2 diabetes can sometimes be challenging.

The distinction matters because the two conditions have different underlying mechanisms and treatment requirements. Type 2 diabetes commonly involves insulin resistance and progressive pancreatic beta-cell dysfunction. Some people with type 2 diabetes can achieve remission following substantial and sustained metabolic improvement, although this is not possible for everyone and does not necessarily eliminate future health risks.

Established type 1 diabetes generally involves a degree of insulin deficiency that requires lifelong replacement therapy. Its management cannot be based on the assumption that changes in diet, physical activity or body weight will restore sufficient insulin production.

There is one circumstance that can create confusion. Shortly after diagnosis and the initiation of treatment, some people with type 1 diabetes experience a temporary period of improved residual insulin secretion. During this partial remission, often called the honeymoon phase, insulin requirements may decrease substantially. This does not mean that the autoimmune condition has been cured or that lifestyle changes have reversed the disease.

The updated 2026 consensus report from the American Diabetes Association and the European Association for the Study of Diabetes emphasizes accurate diagnosis and individualized management, particularly when diabetes develops in adulthood and its classification is uncertain. Clinical history, diabetes-related autoantibodies and C-peptide measurements may help establish the diagnosis in appropriate circumstances.

These investigations require careful interpretation. A detectable C-peptide level does not automatically exclude type 1 diabetes, particularly early in the disease when some endogenous insulin secretion may remain. Misclassification can delay necessary treatment and expose a person to preventable metabolic deterioration.

Lifestyle Medicine should therefore begin with an accurate understanding of the condition being managed. Recommendations that may be appropriate for type 2 diabetes cannot automatically be transferred to type 1 diabetes.

Insulin Treatment Remains Essential

Insulin does more than correct high glucose readings. It is an essential hormone involved in glucose regulation, energy metabolism and the suppression of excessive ketone production.

In established type 1 diabetes, insufficient insulin can lead to significant hyperglycemia, excessive ketone production and diabetic ketoacidosis, a potentially life-threatening metabolic emergency.

Insulin replacement generally needs to address both ongoing basal requirements and additional needs associated with meals, glucose correction and changing physiological circumstances. Treatment may involve multiple daily injections or an insulin pump, depending on clinical needs, treatment availability, individual preferences and the person's ability to manage the regimen safely.

Insulin requirements are not constant. Physical activity, food intake, illness, stress and other factors can influence insulin sensitivity and glucose patterns. Someone who becomes more physically active may require less insulin at certain times, while a person who changes their eating pattern may need adjustments to mealtime insulin.

These changes can be part of appropriate diabetes management, but they do not remove the underlying physiological requirement for insulin. A lower daily insulin dose is not automatically evidence of better health. The more meaningful objective is effective glucose management while minimizing hypoglycemia, dangerous hyperglycemia, acute complications and unnecessary treatment burden.

People with type 1 diabetes should receive structured education that helps them manage daily variations within an individualized treatment plan developed with their diabetes care team. This may include learning how to adjust insulin appropriately in response to food, physical activity and glucose measurements.

Supported self-management is an important part of modern diabetes care. It is different from independently discontinuing insulin or making substantial treatment changes outside an agreed plan.

This distinction becomes particularly important during fasting, acute illness or periods of reduced food intake. Even when someone is eating very little, ongoing basal insulin generally remains necessary to prevent excessive ketone production.

No established dietary pattern, exercise program, fasting regimen, supplement or behavioral intervention can replace necessary insulin therapy in established type 1 diabetes. Lifestyle interventions must work alongside this treatment framework rather than being presented as an alternative to it.

Nutrition: Matching Food, Insulin and Everyday Life

Nutrition therapy is central to type 1 diabetes management, but its purpose is not simply to restrict carbohydrate intake or eliminate particular foods.

Carbohydrates are the main dietary determinant of glucose changes after meals. For people using mealtime insulin, understanding the relationship between carbohydrate intake and insulin administration is an important part of effective self-management.

Carbohydrate counting is one established approach, particularly when insulin doses are adjusted according to the amount of carbohydrate consumed. However, it is not the only suitable method. The updated 2026 international consensus recognizes that relatively consistent carbohydrate intake and experience-based estimation may also be appropriate, depending on the individual's treatment plan, preferences and ability to use the method effectively.

Meal composition matters as well. Fat, protein and fiber can influence the timing and magnitude of glucose responses, particularly after mixed meals. Two meals containing similar amounts of carbohydrate may produce different glucose patterns because of their other ingredients, preparation methods or timing relative to insulin administration.

These considerations should inform nutrition education without making ordinary eating unnecessarily complicated. The objective is to help people understand their own glucose responses, maintain adequate nutrition and make informed choices that fit their daily lives.

Personalized medical nutrition therapy delivered by an appropriately qualified dietitian with experience in diabetes care can help translate these principles into a practical eating plan. Food preferences, cultural background, health literacy, financial circumstances, medical conditions and the insulin regimen should all be considered.

In Viet Nam, nutrition education needs to reflect familiar foods and eating practices rather than relying exclusively on examples drawn from Western diets.

Rice, phở, bún, other noodle dishes, vegetables, fish, meat, legumes and fruit can all form part of an individualized eating plan. The relevant considerations include portion size, carbohydrate content, overall nutritional quality and the relationship between food intake and insulin treatment.

For example, the carbohydrate content of a bowl of phở depends partly on the quantity of noodles. The amount of rice served with a meal may vary considerably between households, restaurants and workplace canteens. Cooking methods and other ingredients can also influence glucose responses.

These differences matter, but they do not justify treating traditional Vietnamese foods as inherently unsuitable for people with type 1 diabetes.

A person eating at a school cafeteria or workplace canteen may have limited control over portion sizes or meal timing. Someone receiving fixed insulin doses may face additional difficulties when their carbohydrate intake varies substantially from day to day. In such circumstances, healthcare professionals should assess whether the current treatment plan remains practical and safe rather than assuming that the person has failed to follow dietary instructions.

Food affordability, household circumstances and access to appropriate nutrition advice may also influence what someone can realistically achieve.

The most useful eating plan is one that supports glucose management, adequate nutrition and a sustainable daily routine while preserving dietary variety and social participation.

Low-Carbohydrate Diets Require Careful Interpretation

Carbohydrate restriction deserves particular attention because the evidence in type 1 diabetes is not identical to that in type 2 diabetes.

Some adults with type 1 diabetes find that reducing carbohydrate intake helps limit glucose fluctuations after meals. The updated 2026 American Diabetes Association and European Association for the Study of Diabetes consensus acknowledges that low-carbohydrate and very-low-carbohydrate eating patterns may be used safely with appropriate education and monitoring. It also describes evidence of short-term improvements in some measures of glucose management.

This should not be interpreted as a recommendation that everyone with type 1 diabetes adopt these eating patterns.

Evidence about long-term safety, nutritional adequacy and sustained clinical benefits remains more limited. Some people may find carbohydrate restriction acceptable and manageable, while others may experience difficulties maintaining dietary variety or integrating the approach with their treatment regimen.

Substantial reductions in carbohydrate intake can alter insulin requirements. Without appropriate adjustment and monitoring, this may increase the risk of hypoglycemia or create other treatment-related problems.

Very-low-carbohydrate and ketogenic diets raise additional concerns. These include the potential for relative insulin deficiency, difficulties managing hypoglycemia and the need to distinguish nutritional ketosis from diabetic ketoacidosis.

Nutritional ketosis and diabetic ketoacidosis are different physiological states. Nevertheless, elevated ketone levels in a person with type 1 diabetes require careful interpretation, particularly when illness, insufficient insulin or other warning signs are present. A ketogenic diet should not be considered protection against diabetic ketoacidosis.

Restrictive eating patterns also require particular attention when there are concerns about weight control, disordered eating or intentional insulin reduction.

For children and adolescents, the evidence and clinical considerations differ from those in adults. Viet Nam's Ministry of Health guidance issued under Decision No. 1760/QĐ-BYT on June 21, 2024, states that evidence for low-carbohydrate and very-low-carbohydrate diets in children and adolescents with type 1 diabetes remains insufficient.

Growth, development and nutritional adequacy must therefore be considered carefully when planning dietary interventions for younger patients.

For adults considering substantial carbohydrate restriction or fasting, healthcare professionals should evaluate the person's clinical circumstances, insulin regimen, nutritional status and ability to monitor glucose and ketones safely.

A responsible Lifestyle Medicine approach should avoid both unconditional promotion and categorical rejection of carbohydrate restriction. The relevant question is whether a particular eating pattern is appropriate, nutritionally adequate, acceptable and safely integrated with insulin therapy for the person concerned.

Physical Activity: Understanding Glucose Responses and Exercise Safety

Regular physical activity can provide important benefits for people with type 1 diabetes.

Aerobic exercise, resistance training and other suitable activities can improve cardiovascular fitness, muscle strength, insulin sensitivity and psychological well-being. Participation in sports and recreational activities can also support social connection, confidence and quality of life.

The updated 2026 international consensus encourages regular physical activity for most people with type 1 diabetes. However, the effects of exercise on glucose levels depend on several interacting factors.

Moderate-intensity aerobic activity may lower glucose during or after exercise, particularly when circulating insulin remains relatively high. Resistance training, high-intensity intervals and competitive sports may produce different responses. In some circumstances, glucose can rise temporarily because of hormonal responses to intense exertion.

The timing of the last meal, recent insulin administration, starting glucose level, exercise intensity, duration and previous experience can all influence the outcome. Even the same person may respond differently to a similar activity on different days.

A short walk after dinner is not equivalent to a prolonged bicycle ride, a competitive football match or an unfamiliar high-intensity workout. Each may require a different approach to glucose monitoring, carbohydrate availability and insulin management.

One particularly important concern is hypoglycemia during or after exercise.

Physical activity increases glucose uptake by skeletal muscle and can alter insulin sensitivity. As a result, glucose may fall during exercise, immediately afterward or several hours later.

The updated 2026 consensus notes that post-exercise hypoglycemia can occur up to 24 hours after physical activity. The risk may be greater following prolonged or unfamiliar exercise and may extend into the evening or overnight.

Someone who completes a workout with an acceptable glucose level may therefore still experience hypoglycemia later. This is why exercise planning should consider more than a single glucose measurement before activity.

Glucose trends, recent insulin administration, previous responses to similar activities and the availability of carbohydrate all contribute to an individualized safety plan.

People at risk of hypoglycemia should have access to a suitable rapid-acting carbohydrate source. Those at risk of severe hypoglycemia need an appropriate emergency response plan, including glucagon when prescribed and available, and education for family members or others who may need to assist.

Severe hypoglycemia can cause seizures or impaired consciousness and requires immediate assistance. Food or drink must not be given orally to someone who cannot swallow safely.

High glucose and elevated ketones introduce a different concern.

A temporary rise in glucose during intense exercise does not necessarily indicate a dangerous metabolic problem. However, hyperglycemia associated with insufficient insulin and elevated ketones may signal developing insulin deficiency and a risk of diabetic ketoacidosis.

Additional physical exertion may worsen metabolic deterioration in these circumstances. Exercise should not be used as a substitute for insulin when hyperglycemia may reflect inadequate insulin replacement.

People with type 1 diabetes should receive individualized instructions about when ketone testing is appropriate, when physical activity should be postponed and when professional or urgent medical assessment is necessary.

Glucose readings, ketone measurements, symptoms and recent insulin administration must be considered together. Importantly, diabetic ketoacidosis can sometimes occur without extremely high glucose levels, so concerning symptoms and ketone results should not be dismissed solely because glucose is lower than expected.

Existing complications may also influence exercise recommendations. Advanced diabetic retinopathy, active foot disease and certain cardiovascular conditions can affect the suitability of particular activities and may require specialist assessment.

The aim is not to discourage people from exercising. It is to provide the knowledge, supplies and clinical support needed for safe participation.

For healthcare professionals delivering Lifestyle Medicine education, exercise-related counseling must remain within their professional competence and legally authorized scope of practice. Individual insulin adjustments and clinical decisions about exercise safety should follow an appropriate diabetes management plan.

Diabetes Technology: Benefits, Limitations and Backup Arrangements

Continuous glucose monitoring has improved the ability of many people with type 1 diabetes to understand their glucose patterns.

These systems provide repeated estimates of glucose levels in interstitial fluid, display trends and, depending on the device, provide alerts when glucose approaches or crosses selected thresholds.

The updated 2026 international consensus identifies continuous glucose monitoring as the preferred approach for adults with type 1 diabetes because of its benefits for glucose management and hypoglycemia prevention.

Automated insulin delivery systems, which combine compatible glucose sensors, insulin pumps and control algorithms, can further improve glucose management for many users. These technologies may be particularly helpful during physical activity, overnight and at times when glucose patterns are changing.

However, an advanced device does not eliminate the need for education, clinical follow-up or backup arrangements.

Continuous glucose monitors estimate glucose in interstitial fluid rather than measuring blood glucose directly. During rapid changes, sensor readings may differ from capillary glucose measurements. Sensors can also become inaccurate, unavailable or disconnected.

When symptoms do not match the displayed glucose value, capillary blood glucose testing may be necessary. People using continuous glucose monitoring should therefore continue to have access to appropriate blood glucose testing supplies and a means of measuring ketones when clinically indicated.

Insulin pump users face an additional safety consideration.

Many insulin pumps deliver rapid-acting insulin without a separate long-acting insulin injection. A blocked infusion set, disconnected cannula, empty reservoir or device failure can interrupt insulin delivery and lead to insulin deficiency.

Because ketosis and diabetic ketoacidosis may develop relatively rapidly after a significant interruption, a backup insulin administration plan is essential.

Automated systems also differ in how much information and user interaction they require. Some depend on meal announcements or other inputs, while newer technologies offer different degrees of automation.

Treatment decisions should reflect the capabilities and limitations of the particular device rather than assuming that all systems function in the same way.

In Viet Nam, access to diabetes technology must also be considered realistically. Evidence of clinical benefit does not establish that every device is legally available, affordable, reimbursed or suitable for every patient.

People using multiple daily injections and capillary glucose monitoring must continue to receive appropriate education and effective care, even when advanced technologies are unavailable.

The quality of diabetes management should be assessed through treatment safety and meaningful outcomes, not simply the sophistication of the equipment someone uses.

Illness, Fasting and the Risk of Interrupted Insulin Treatment

Managing type 1 diabetes can become substantially more difficult during acute illness.

Fever, infection, vomiting, dehydration and physiological stress can change insulin requirements and increase the risk of diabetic ketoacidosis. At the same time, reduced appetite or gastrointestinal symptoms may make normal food intake difficult.

Someone who is eating very little may assume that insulin is no longer necessary. In established type 1 diabetes, this assumption can be dangerous.

The body continues to require insulin even when carbohydrate intake is reduced or absent. Basal insulin remains important for meeting physiological needs and preventing excessive ketone production.

Insulin requirements may need adjustment during illness, but stopping basal insulin without an appropriate medical plan can create serious risks.

This makes individualized sick-day education an essential component of diabetes care. Patients and caregivers should understand when glucose and ketone monitoring needs to increase, how to follow the agreed insulin management plan, when to obtain professional advice and which symptoms require urgent evaluation.

Persistent vomiting, abdominal pain, dehydration, deep or rapid breathing, confusion or significant ketone elevation may indicate diabetic ketoacidosis and require urgent medical assessment.

Diabetic ketoacidosis is a potentially life-threatening emergency. It cannot be managed safely through lifestyle advice, hydration or exercise alone.

Treatment continuity also matters outside periods of illness.

People who travel frequently, work irregular shifts or live far from their usual healthcare providers may face practical difficulties maintaining insulin supplies, monitoring equipment and medical follow-up.

In Viet Nam, hot weather and prolonged travel can create additional insulin storage challenges. Insulin should be transported and stored according to the relevant manufacturer's instructions, with appropriate protection from excessive heat and freezing.

People using insulin pumps may need additional infusion supplies, backup equipment and a clear plan for obtaining alternative insulin delivery if their device fails.

These arrangements may appear separate from conventional lifestyle counseling, but they affect whether someone can safely participate in ordinary life.

A person should not have to avoid travel, employment or physical activity simply because their diabetes management requires additional preparation. Equally, maintaining those activities should not come at the expense of uninterrupted essential treatment.

Children, Adolescents and Participation in School Life

Type 1 diabetes management requires particular attention during childhood and adolescence.

Children have changing nutritional requirements, patterns of physical activity and insulin needs. As they grow older, they gradually assume more responsibility for glucose monitoring, insulin administration and daily treatment decisions.

The updated 2026 international consensus from the American Diabetes Association and European Association for the Study of Diabetes focuses on adults. Pediatric management requires age-appropriate guidance rather than automatic application of recommendations developed for older patients.

Viet Nam has a dedicated national professional resource for this population.

On June 21, 2024, the Ministry of Health issued Decision No. 1760/QĐ-BYT, introducing the Guidelines for Diagnosis and Treatment of Type 1 Diabetes in Children and Adolescents. The document addresses insulin treatment, nutrition, physical activity, glucose monitoring, hypoglycemia, diabetic ketoacidosis and other aspects of pediatric care.

Its recommendations also recognize the importance of family circumstances and the school environment.

A student with type 1 diabetes may need to check glucose, administer insulin, eat a snack or respond to hypoglycemia during the school day. Physical education, sports competitions, examinations and school excursions can require additional planning.

Teachers and relevant school personnel may need appropriate information and training to recognize hypoglycemia and respond according to the child's agreed diabetes care and emergency plans.

Communication among families, schools and healthcare professionals can help ensure that these arrangements support both safety and participation.

The goal should not be to exclude children from ordinary school activities because of their diagnosis. It should be to make participation safer through appropriate planning, communication and access to necessary supplies and assistance.

As adolescents become more independent, diabetes education should support their growing capacity for self-management without expecting them to assume every responsibility immediately.

Body image, psychological well-being, eating behavior and the burden of ongoing treatment also deserve attention during this period.

The transition from pediatric to adult diabetes care is another important consideration. Changes in healthcare providers, treatment arrangements and daily responsibilities should be managed in ways that reduce the risk of disrupted care.

Psychological Well-Being Is Part of Diabetes Safety

Living with type 1 diabetes involves continuous attention to decisions that other people may rarely need to consider.

Food, exercise, travel, illness and sleep can all affect glucose levels. The need for repeated monitoring and treatment decisions can become exhausting, especially when glucose patterns remain difficult to predict despite considerable effort.

Diabetes distress refers to the emotional burden associated with living with and managing diabetes. It is distinct from depression and anxiety, although these conditions may coexist.

Fear of hypoglycemia may lead some people to avoid exercise or deliberately maintain glucose levels above their recommended range. Others may experience frustration, treatment fatigue or anxiety related to glucose-monitoring alarms and the demands of everyday self-management.

These concerns should be addressed without implying that people are personally responsible for every glucose fluctuation.

An elevated or low glucose reading is clinical information. It is not a measure of personal success or failure.

In September 2026, the European Association for the Study of Diabetes published an evidence-based clinical practice guideline addressing diabetes distress in adults with type 1 and type 2 diabetes.

The guideline supports identifying diabetes distress, understanding its sources and developing an appropriate shared management plan. It conditionally recommends considering psychological interventions alongside usual care for adults with type 1 diabetes, while recognizing limitations in the certainty of the evidence.

It also identifies the potential for continuous glucose monitoring to reduce diabetes distress in some adults with type 1 diabetes, although device availability, individual preferences and possible burdens such as frequent alarms must be considered.

Not every person experiencing diabetes distress requires the same intervention.

Some may benefit from reviewing a burdensome treatment routine, improving access to practical self-management support or addressing fear of hypoglycemia. Others may require structured psychological treatment or multidisciplinary assessment.

Particular care is needed when insulin restriction or omission is associated with weight-control concerns or disordered eating, as this can carry serious medical risks.

Psychological support must also remain connected to medical assessment. Recurrent hypoglycemia, inappropriate insulin dosing, device malfunction and other clinical problems should not be overlooked because someone is experiencing distress.

Lifestyle Medicine can contribute through supportive communication, realistic goal-setting and attention to the person's circumstances, while recognizing when specialist medical or mental health care is required.

Long-Term Health Goes Beyond Glucose Control

Glucose management is central to type 1 diabetes care, but long-term health depends on more than glucose levels alone.

People with type 1 diabetes may develop cardiovascular disease, kidney disease, retinopathy, neuropathy and other complications. They may also experience obesity, insulin resistance, hypertension or dyslipidemia.

The updated 2026 international consensus gives greater attention to cardiovascular risk factors, obesity and long-term complications in adults with type 1 diabetes.

Appropriate monitoring of blood pressure, lipid levels, kidney function, eye health and other relevant indicators remains important, according to individual risk and applicable clinical guidance.

Healthy eating, regular physical activity, smoking cessation, adequate sleep and psychological support can contribute to better overall health. However, these interventions should not delay indicated medical treatment for hypertension, dyslipidemia, kidney disease or other conditions.

A person with type 1 diabetes may follow a healthy lifestyle and still require additional medications or specialist treatments to reduce long-term complications.

The objective is comprehensive, sustainable care that protects health and quality of life, rather than a narrow focus on reducing insulin doses or achieving an improved laboratory result at a single appointment.

Strengthening Treatment Continuity in Viet Nam

Integrating Lifestyle Medicine into type 1 diabetes management in Viet Nam does not necessarily require creating a separate system of care.

A practical starting point is to strengthen how existing diabetes services connect insulin treatment, nutrition education, physical activity counseling, glucose monitoring, psychological support and continuing follow-up.

Healthcare professionals should consider not only what treatment is clinically appropriate, but also whether the person can realistically maintain it.

Someone may understand their insulin regimen but experience difficulty obtaining supplies consistently. A university student may find it challenging to coordinate meals, injections and monitoring with an unpredictable schedule. A person working rotating shifts may experience changes in sleep, eating patterns and physical activity that complicate glucose management.

These situations should not automatically be interpreted as failures of motivation or treatment adherence. They may reflect the interaction between clinical requirements and the social, economic and practical conditions in which people live.

The 2025 Lifestyle Medicine Core Competencies explicitly recognize the importance of social determinants of health. This includes adapting lifestyle interventions to individual circumstances and addressing barriers that influence people's ability to benefit from healthcare.

For people with type 1 diabetes, access to insulin and essential monitoring supplies is particularly important because treatment interruption can have immediate and serious consequences.

The World Health Organization's Global Diabetes Compact includes a target that, by 2030, all people with type 1 diabetes should have access to affordable insulin and blood glucose self-monitoring.

This is a global objective, not evidence that universal access has already been achieved in Viet Nam.

It nevertheless highlights an important principle: education about healthy living cannot compensate for unreliable access to essential treatment.

For healthcare organizations, useful improvements may include identifying patients at risk of interrupted insulin supplies, ensuring that individualized sick-day and emergency plans are available, reviewing treatment after serious glucose-related events and supporting safe transitions between healthcare services.

Nurses, dietitians, diabetes educators and other appropriately qualified healthcare professionals can contribute within their professional responsibilities. Coordination with the treating medical team remains essential for clinical decisions involving insulin and the management of complications.

These activities should be integrated into existing treatment pathways rather than delivered as disconnected wellness services.

An effective approach recognizes that successful diabetes management depends not only on clinical knowledge, but also on whether safe treatment can be maintained throughout everyday life.

Professional Responsibilities and Legal Boundaries in Viet Nam

Lifestyle Medicine can support healthcare professionals in understanding nutrition, physical activity, sleep, behavior change and the wider circumstances affecting people with type 1 diabetes. However, education about Lifestyle Medicine does not create an independent right to undertake regulated medical activities.

In Viet Nam, the Law on Medical Examination and Treatment, as reflected in Consolidated Document No. 26/VBHN-VPQH dated February 26, 2026, provides the relevant legal framework for medical practice.

Diagnosis, medical treatment, insulin prescribing, clinical medication adjustments and management of acute metabolic complications must be undertaken by appropriately qualified healthcare professionals acting within their legally authorized scope of practice.

Completing a Lifestyle Medicine course, international certification program or health-coaching training does not independently authorize someone to diagnose type 1 diabetes, prescribe insulin or make clinical treatment decisions outside that scope.

The Law on Disease Prevention No. 114/2025/QH15, effective July 1, 2026, provides a broader national framework for disease prevention and health promotion, including the prevention and management of noncommunicable diseases and their consequences.

Its relevance to type 1 diabetes lies particularly in supporting long-term health management and the prevention of complications. It should not be interpreted as evidence that lifestyle modification can prevent autoimmune type 1 diabetes or as authorization for a new independent clinical scope of practice.

International consensus recommendations can inform professional education and clinical quality improvement. However, they do not automatically become Vietnamese prescribing regulations or establish the approval, reimbursement or availability of particular insulin formulations, glucose-monitoring systems or automated insulin delivery technologies.

Digital monitoring also introduces important privacy responsibilities.

Glucose records, insulin administration histories, medical diagnoses and other identifiable health information must be handled in accordance with applicable confidentiality and personal data protection requirements.

Viet Nam's Law on Personal Data Protection No. 91/2025/QH15 and Decree No. 356/2025/NĐ-CP, both effective January 1, 2026, are relevant to organizations processing personal health information.

Appropriate safeguards, lawful processing arrangements and clear responsibilities are necessary when diabetes-related information is collected, stored or shared through digital devices, applications or healthcare services.

For the Vietnam Lifestyle Medicine Alliance, the appropriate contribution is to promote evidence-informed professional education, responsible health communication and interdisciplinary collaboration while respecting the clinical and legal boundaries of diabetes care.

Measuring Outcomes That Matter

The success of a Lifestyle Medicine intervention for type 1 diabetes should not be assessed solely by changes in dietary habits, exercise frequency or body weight.

These measures can describe participation, but they do not establish whether diabetes management has become safer or more effective.

Glycated hemoglobin remains an important indicator of longer-term glucose management. However, it does not fully describe glucose variability or the frequency and severity of hypoglycemia.

Where continuous glucose monitoring is available, measures such as time in range, time below range and time above range can provide additional information.

Targets should be individualized according to clinical circumstances rather than applied rigidly to every person.

Improving average glucose levels while causing repeated severe hypoglycemia cannot be considered a successful intervention simply because a laboratory value has improved.

Other meaningful outcomes include episodes of diabetic ketoacidosis, severe hypoglycemia requiring assistance, treatment interruptions, diabetes-related hospitalizations and access to necessary medication and monitoring supplies.

Quality of life, diabetes distress and confidence in managing treatment safely also deserve attention.

For someone who has avoided physical activity because of fear of hypoglycemia, being able to participate in regular exercise safely may represent meaningful progress. For an adolescent, attending school and participating in sports without repeated treatment disruption may be equally important.

Healthcare organizations can also assess whether patients receive appropriate self-management education, have individualized sick-day plans, receive follow-up after serious glucose-related events and experience safe transitions between services.

These measures should be selected for their clinical usefulness and their potential to improve care, rather than simply adding documentation requirements.

Better diabetes care is not defined by the number of lifestyle counseling sessions delivered. It is reflected in treatment safety, improved functioning and outcomes that matter to the person living with the condition.

Healthy Living and Essential Treatment Must Work Together

Type 1 diabetes provides a clear example of why Lifestyle Medicine cannot be reduced to the idea that healthier behaviors should replace medication.

Nutrition, physical activity, restorative sleep, psychological well-being and social support can improve important aspects of life with diabetes. They can contribute to better health, support glucose management and help people participate more fully in everyday activities.

However, established type 1 diabetes involves an essential requirement for insulin replacement. The value of lifestyle support should therefore be assessed by how effectively it complements necessary medical treatment, not by whether it reduces or eliminates insulin use.

The updated 2026 international consensus emphasizes personalized care, advances in diabetes technology, structured self-management education and attention to long-term physical and psychological health.

In Viet Nam, these principles need to be applied in ways that reflect familiar foods, school and work responsibilities, access to healthcare and the practical realities of maintaining treatment over many years.

Someone living with type 1 diabetes should be able to enjoy familiar meals, participate in physical activity and pursue a fulfilling life without compromising essential treatment.

Good care should help make these goals compatible.

The contribution of evidence-based Lifestyle Medicine is to support that process through appropriate education, individualized interventions, clinical collaboration and attention to the person's circumstances.

For type 1 diabetes, healthier living and uninterrupted insulin therapy are not competing approaches. They are complementary parts of safe, sustainable and person-centered care.

Selected References

1. Holt RIG, DeVries JH, Hess-Fischl A, et al. The Management of Type 1 Diabetes in Adults: The Updated 2026 Consensus Report by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. Published September 15, 2026. doi:10.2337/dci26-0122.

2. American Diabetes Association Professional Practice Committee for Diabetes. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1). doi:10.2337/dc26-S005.

3. American Diabetes Association Professional Practice Committee for Diabetes. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1). doi:10.2337/dc26-S006.

4. American Diabetes Association Professional Practice Committee for Diabetes. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1). doi:10.2337/dc26-S009.

5. American Diabetes Association Professional Practice Committee for Diabetes. Children and Adolescents: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1)–S320. doi:10.2337/dc26-S014.

6. Speight J, Hermanns N, Jensen W, et al. 2026 EASD Evidence-Based Clinical Practice Guideline for Assessing and Managing Diabetes Distress Among Adults With Type 1 Diabetes or Type 2 Diabetes. Diabetologia. Published September 15, 2026. doi:10.1007/s00125-026-06840-0.

7. World Health Organization. Diabetes: WHO's Response. Updated September 1, 2026.

8. Ministry of Health of Viet Nam. Decision No. 1760/QĐ-BYT, dated June 21, 2024. Guidelines for Diagnosis and Treatment of Type 1 Diabetes in Children and Adolescents.

9. Rea BL, Cheema S, Lanza S, et al. Lifestyle Medicine Core Competencies: 2025 Update. American Journal of Lifestyle Medicine. Published online October 28, 2025. doi:10.1177/15598276251379821.

10. Office of the National Assembly of Viet Nam. Consolidated Document No. 26/VBHN-VPQH, dated February 26, 2026. Law on Medical Examination and Treatment.

11. National Assembly of Viet Nam. Law No. 114/2025/QH15, dated December 10, 2025. Law on Disease Prevention. Effective July 1, 2026.

12. National Assembly of Viet Nam. Law No. 91/2025/QH15, dated June 26, 2025. Law on Personal Data Protection. Effective January 1, 2026.

13. Government of Viet Nam. Decree No. 356/2025/NĐ-CP, dated December 31, 2025. Detailing Certain Articles and Measures for the Implementation of the Law on Personal Data Protection. Effective January 1, 2026.

Editorial, Clinical and Legal Disclaimer

This article is published by Vietnam Lifestyle Medicine Alliance (VLMA) for general information and professional education. It provides an evidence-informed discussion of Lifestyle Medicine in type 1 diabetes care and does not constitute an official clinical practice guideline, individualized medical advice, a dietary prescription, an exercise prescription, an insulin dosing protocol or a treatment plan.

Lifestyle interventions do not cure established type 1 diabetes and must not replace, delay or interrupt necessary insulin therapy. The information in this article must not be used to independently diagnose diabetes, initiate or discontinue insulin, make unsupervised treatment changes, determine individualized exercise-related medication adjustments or manage suspected diabetic ketoacidosis without appropriate professional assessment.

People with severe hypoglycemia, suspected diabetic ketoacidosis, persistent vomiting, altered consciousness or other acute warning signs require urgent medical attention. General lifestyle advice must not delay emergency assessment or treatment.

The updated 2026 international consensus report discussed in this article focuses on adults with type 1 diabetes. Pediatric clinical decisions require age-appropriate professional guidance, including relevant Vietnamese Ministry of Health recommendations.

International clinical recommendations do not automatically constitute Vietnamese prescribing regulations or establish the regulatory approval, availability, reimbursement or suitability of particular insulin formulations, glucose-monitoring devices or automated insulin delivery technologies in Viet Nam.

All regulated clinical activities must be undertaken by appropriately qualified healthcare professionals acting within their legally authorized scope of practice and applicable Vietnamese requirements. Personal health information must be handled in accordance with applicable confidentiality and personal data protection obligations.

VLMA does not endorse any particular commercial diet, insulin brand, glucose-monitoring device, insulin pump, supplement or unproven treatment through this article.

The content reflects the scientific evidence, professional guidance and legal framework reviewed as of October 30, 2026, and may require updating as research, clinical recommendations and Vietnamese regulations evolve.